Lamogin 25 mg (Tablet)

Unit Price: ৳ 10.00 (3 x 10: ৳ 300.00)
Strip Price: ৳ 100.00

Medicine Details

Indications

  • Adjunctive therapy for partial-onset seizures
  • Adjunctive therapy for primary generalized tonic-clonic seizures
  • Adjunctive therapy for generalized seizures of Lennox-Gastaut syndrome
  • Monotherapy for epilepsy in patients aged 16 years and older
  • Treatment of bipolar disorder in patients aged 18 years and older

Description

  • Phenyltriazine antiepileptic medication
  • Used to control epileptic seizures
  • Inhibits voltage-sensitive sodium channels
  • Stabilizes neuronal membranes
  • Inhibits presynaptic excitatory neurotransmitter release

Pharmacology

  • Inhibits voltage-sensitive sodium channels
  • Modulates release of presynaptic excitatory neurotransmitters
  • Weak inhibitory effect on serotonin 5-HT3 receptor
  • Binds weakly to multiple receptors including adrenergic, dopamine, and GABA receptors
  • Inhibits Cav2.3 (R-type) calcium currents
  • May have clinical benefit in some neuropathic pain states

Dosage & Administration

  • Dosing regimen for patients older than 12 years with epilepsy
  • Dosing regimen for patients aged 2 to 12 years with epilepsy
  • Dosing regimen for adults with bipolar disorder

Interaction

  • Valproate increases Lamogin concentrations more than 2-fold
  • Carbamazepine, phenytoin, phenobarbital, primidone, and rifampin decrease Lamogin concentrations by approximately 40%
  • Estrogen-containing oral contraceptives decrease Lamogin concentrations by approximately 50%
  • Protease inhibitors lopinavir/ritonavir and atazanavir/ritonavir decrease Lamogin exposure by approximately 50% and 32% respectively

Side Effects

  • Dizziness
  • Headache
  • Diplopia
  • Ataxia
  • Nausea
  • Blurred vision
  • Somnolence
  • Pharyngitis
  • Rash
  • Vomiting (in children)
  • Diarrhea (in children)
  • Infection (in children)
  • Fever (in children)
  • Abdominal pain (in children)
  • Tremor (in children)

Pregnancy & Lactation

  • Pregnancy Category C
  • Excreted in human milk
  • Consideration for discontinuation of nursing or drug

Precautions & Warnings

  • Discontinue at first sign of rash
  • Monitor for blood dyscrasias
  • Monitor for suicidal behavior and ideation
  • Monitor for signs of aseptic meningitis

Use in Special Populations

  • Adjunctive treatment for partial onset seizures not demonstrated in very young pediatric patients (aged 1 to 24 months)
  • Maintenance treatment for bipolar disorder not established in pediatric patients (aged 10 to 17 years)

Overdose Effects

  • Ataxia
  • Nystagmus
  • Seizures
  • Decreased level of consciousness
  • Coma
  • Intraventricular conduction delay

Therapeutic Class

  • Primary anti-epileptic drugs

Storage Conditions

  • Keep out of reach of children
  • Store in a dry place
  • Below 25°C temperature
  • Protected from light

Related Brands